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Psychiatric disorders are known to result from a 
strong interaction between genetic predisposition and 
environmental factors, mainly exposure to stressful events. 
Environmental events can modulate genes expression, 
possibly via epigenetic mechanisms, and affect onset/
expression of a disease [1]. Epigenetic mechanisms 
include, among others, post-transcriptional regulation 
by non-coding RNAs such as microRNAs (miRNAs). 
MiRNAs are small non-coding RNAs predicted to 
regulate hundreds of targets and to be engaged in every 
biological process [2]. Thanks to their ability to fine-tune 
gene expression, miRNAs can control gene expression 
patterns favoring organism’s adaptation to internal and 
environmental (external) factors [3], such as stressful 
events. 
Studies in humans and in animal models have 
provided important insights into the role of miRNAs in 
different psychiatric disorders, showing that miRNAs are 
involved in neuroplasticity, neuronal adaptation to stress, 
and stress-related disorders including anxiety, depression, 
and bipolar disorder [1, 3-5]. In particular, animal models 
offer the opportunity to correlate miRNA expression 
in specific brain structures with different behavioral 
phenotypes [1, 3-5].
Recent evidence point to members of the miRNA-34 
family of miRNAs as a critical modulators of stress 
response, showing their role in the manifestation of fear 
and anxiety-related behaviors [6, 7]. Although different 
brain areas are involved in stress response modulation, 
the medial preFrontal Cortex (mpFC) and the amygdala 
are crucially affected by stressful stimuli, and multiple 
lines evidence indicate that dysfunction of the neural 
circuit connecting these two structures underlies stress-
related anxiety-like disorders [7]. Interestingly, miRNA-
34c (a member of the miR-34 family) has been reported 
to be up-regulated in the central nucleus of the Amygdala 
following acute and chronic stress in mice [6]. Moreover, 
local inhibition of miRNA-34c increased anxiety-like 
behavior, while its ectopic expression partially reverted 
this phenotype [6]. 
We have recently demonstrated that serotonergic 
prefrontal transmission modulates the stress response 
acting on GABAergic transmission within the basolateral 
amygdala (BLA) in mice [8]. Using mice carrying a 
targeted deletion of miR-34a, miR-34b, and miR-34c 
(TKO), we have shown that miRNA-34 expression within 
the prefrontal-amygdala brain circuit regulates stress 
response. We evaluated the role of miRNA-34 in stress 
response by subjecting wild type (WT) and TKO mice to 
different anxiety-related tests (elevated plus maze, dark-
light and open field tests). We also investigated prefrontal 
serotonergic-amygdalar GABAergic release induced 
by acute restraint stress exposure as well as dendritic 
remodeling induced by stress in the BLA of WT and TKO 
mice. We found that TKO mice had a reduced behavioral 
(anxiety-like behaviors), morphological (reduced spine 
density, numbers of branch points, dendritic length in 
amygdala), and neurochemical (prefrontal serotonin/
norepinephrine-amygdalar GABAergic release) response 
to acute stress exposure, thus suggesting that absence 
of miRNA-34 protects from stress-induced anxiety-like 
phenotype expression. 
Interestingly, under unstressed conditions WT and 
TKO animals did not show any significant difference 
in anxiety-like behaviors, neurotransmission and 
morphological parameters in the BLA. This is consistent 
with the view that many miRNAs act as modulators of 
stress responses and with the observation that many 
miRNA knockout animals display altered phenotypes only 
following environmental stress exposure [2].
Although data from knockout models might partially 
be affected by developmental compensatory modifications, 
our data point to a modulatory role of miRNA-34 in the 
response of prefrontal serotonergic-amygdalar GABAergic 
brain circuit to stress events, in agreement with studies 
suggesting specific functions of miRNAs in the regulation 
of brain neurotransmission activity.
Investigating and confirming the interaction 
between miRNA-34 and its putative target genes will 
shed light on the mechanisms by which miRNA-34 can 
regulate different biological processes, including stress 
response. Among the putative targets, the stress-related 
corticotropin releasing factor receptor type 1 (CRF1) 
mRNA is one of the most important target of miRNA-34, 
and the role of miRNA-34 as regulator of CRF signaling 
has been recently reported demonstrating that miRNA-34 
reduced the responsiveness to CRF of CRFR1-expressing 
neuronal cells [6]. Because reduced stress effects (and 
increased “active coping” behavior) have been associated 
to a inhibition of dorsal raphe nuclei (DRN)-serotonin 
system projecting to the pFC mediated by endogenous 
CRF through CRFR1 receptor and we observed a reduced 
prefrontal serotonergic response to stress in TKO mice, 
we speculate, also based on preliminary data from our 
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laboratory (data not shown) that “resilience” to stress 
showed by TKO animals might be due to increased DRN 
CRF1 receptors expression (induced by miRNA-34 lack), 
that inhibits serotonin prefrontal stress-induced release 
thus blunting amygdalar GABAergic outflow and, lastly, 
promoting a more “resilient” phenotype. 
Overall, these data indicate an important role of the 
miR-34 family in modulating stress responses in the CNS. 
Further studies investigating whether miR-34-related-
single nucleotide polymorphisms can be used as predictive 
risk indicators for the expression of psychopathologies 
induced by stress are certainly warranted. 
Finally, peripheral circulating miRNAs have 
been proposed as potential biomarkers of different 
psychopathologies and useful tools to evaluate treatment 
response [1, 5]. Despite some promising results in this 
area, much more has to be done to elucidate the functions 
of these small non-coding RNAs and to understand their 
potential role in the molecular pathways altered in many 
psychopathologies.
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